AU2003274059A1 - Combination of a trioxopyrimidine compound inhibitor and an anti-tumor agent, and uses thereof - Google Patents

Combination of a trioxopyrimidine compound inhibitor and an anti-tumor agent, and uses thereof

Info

Publication number
AU2003274059A1
AU2003274059A1 AU2003274059A AU2003274059A AU2003274059A1 AU 2003274059 A1 AU2003274059 A1 AU 2003274059A1 AU 2003274059 A AU2003274059 A AU 2003274059A AU 2003274059 A AU2003274059 A AU 2003274059A AU 2003274059 A1 AU2003274059 A1 AU 2003274059A1
Authority
AU
Australia
Prior art keywords
combination
tumor agent
compound inhibitor
trioxopyrimidine compound
trioxopyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003274059A
Other versions
AU2003274059A8 (en
Inventor
Matthias Arlt
Sabine Bauer
Hans-Willi Krell
Achim Krueger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU2003274059A8 publication Critical patent/AU2003274059A8/en
Publication of AU2003274059A1 publication Critical patent/AU2003274059A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003274059A 2002-10-23 2003-10-22 Combination of a trioxopyrimidine compound inhibitor and an anti-tumor agent, and uses thereof Abandoned AU2003274059A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02023710.3 2002-10-23
EP02023710 2002-10-23
PCT/EP2003/011682 WO2004037286A2 (en) 2002-10-23 2003-10-22 Combination of a trioxopyrimidine compound inhibitor and an anti-tumor agent, and uses thereof

Publications (2)

Publication Number Publication Date
AU2003274059A8 AU2003274059A8 (en) 2004-05-13
AU2003274059A1 true AU2003274059A1 (en) 2004-05-13

Family

ID=32116222

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003274059A Abandoned AU2003274059A1 (en) 2002-10-23 2003-10-22 Combination of a trioxopyrimidine compound inhibitor and an anti-tumor agent, and uses thereof

Country Status (2)

Country Link
AU (1) AU2003274059A1 (en)
WO (1) WO2004037286A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009079585A2 (en) 2007-12-17 2009-06-25 Dyax Corp. Compositions and methods for treating osteolytic disorders comprising mmp-14 binding proteins
JP2011517320A (en) * 2008-03-03 2011-06-02 ダイアックス コーポレーション Metalloprotease 9 binding protein and metalloprotease 2 binding protein
EP2262529A4 (en) 2008-03-03 2013-05-08 Dyax Corp Metalloproteinase 9 binding proteins
US10314909B2 (en) 2011-10-21 2019-06-11 Dyax Corp. Combination therapy comprising an MMP-14 binding protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2852192B2 (en) * 1994-07-08 1999-01-27 カンセアフォースクニングスフォンデン・アフ・１９８９（フォンデン・チル・フレメ・アフ・エクスペリメンテル・カンセアフォースクニング） uPAR binding site of domain 2 + 3 of uPAR and antibody
WO1997041844A1 (en) * 1996-05-09 1997-11-13 Alcon Laboratories, Inc. Combinations of angiostatic compounds

Also Published As

Publication number Publication date
AU2003274059A8 (en) 2004-05-13
WO2004037286A2 (en) 2004-05-06
WO2004037286A3 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
AU2003202263A1 (en) Roh-kinase inhibitors
AU2003300832A1 (en) NF-KappaB INHIBITORS
AU2003248122A1 (en) Sodium channel inhibitor
AU2003249683A1 (en) Nf-:b inhibitors
AU2003277721A1 (en) Beta-nitrostyrene compound and telomerase inhibitor having an anticancer activity
AU2003244750A1 (en) Polymerisation inhibitor
AU2003222197A1 (en) Inhibition of rna function
AU2003230392A1 (en) Beta-secretase inhibitors
AU2003236907A1 (en) Clasp
AU2003273819A1 (en) Coating agent
AU2003275505A1 (en) Electowinning of metals
AU2003252593A1 (en) Sulfotransferase inhibitors
AU2003302946A1 (en) A small hardware implementation of the subbyte function of rijndael
AU2003289207A1 (en) Anti-inflammatory agent
AU2003244080A1 (en) Phosphodiesterase inhibitor
AU2003224941A1 (en) NF-KappaB INHIBITORS
AU2003274059A1 (en) Combination of a trioxopyrimidine compound inhibitor and an anti-tumor agent, and uses thereof
AU2003218049A1 (en) Targeted immunotherapy of acute lymphoblastic leukemia (all)
AUPS044102A0 (en) New compound
AU2003232189A1 (en) Antifouling agent
AU2003207181A1 (en) Microorganism-trapping agent
AU2002951868A0 (en) Compound i
AU2002305868A1 (en) Inhibitors of reggamma
AU2003210389A1 (en) Nitro-derivatives of oligosaccharides
AU2003206372A1 (en) Fluorinated activator

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase